• Friendable acquired Artist Republik and FeaturedX to compliment the Fan Pass Live brand in January 2022
• Since then, Friendable has continued to put focus on the newly acquired brands, paying particular attention to phase II of FeaturedX
• The company believes that phase II changes are contributing to a revenue increase, with total gross orders received in the first six months of the year reaching approximately $170,000
• The global independent artists and performing arts companies market is expected to reach $328.87 billion by 2026, growing at a CAGR of 19%

Friendable (OTC: FDBL), a mobile technology and marketing company focused on the development and identification of products, services, and brand opportunities with mass-market potential and scalability, recently announced its company metrics from the previous six months following the acquisition of Artist Republik and FeaturedX brands/offerings. The company announced the successful acquisition of Artist Republik and FeaturedX in January 2022 and, combined with Fan Pass Live, has created the ultimate “anti-label” 360-degree artist platform offering (https://ibn.fm/akouE). Since the acquisition was completed, Friendable’s management team has been focused on both offerings, starting with Artist Republik and now the recent phase II upgrade of FeaturedX. The company determined the key to FeaturedX’s future success was the necessity to overhaul the communication tools between artists and the company and between “featuring artist” and the artist interested in purchasing their services. According to Friendable CEO Robert A. Rositano Jr., it has been the company’s mission to provide a full 360 offering for all independent music artists and believes it has achieved this by offering a comprehensive suite of services that include music distribution, music writing and video collaboration, design services, promotional materials, merch designs/collections, and e-commerce storefronts. “It’s all here in one place and let’s not forget about the ‘Live’ with Fan Pass Live, which brings the virtual live event scheduling, ticket sales, tips, backstage action/content, merch promo/sales, and fan interaction with revenue sharing for artists across the board, that’s what we call a 360 offering,” he said. The company is uniquely positioned to tap into a significant segment of the global independent artists and performing art companies market, a market that was valued at $101.33 billion in 2021 and is expected to reach $163.14 billion in 2022. By 2026, the market is expected to reach $328.87 billion by 2026, growing at a CAGR of 19% (https://ibn.fm/0Mmiu). Friendable believes FeaturedX has been one of the primary factors driving platform growth over the last six months, helping achieve a total of 270 gross orders. The FeaturedX offering has given the company significant traction in building a revenue ramp that adds to its existing base and requires additional technology upgrades and features that close the loop between artists and their fanbase. In the past, artists were required to approve orders before payment, creating a drop-off in collected revenue, which the company has since corrected with payments required upfront. Friendable released a snapshot of FeaturedX’s traction and activity metrics, showing that the total number of users is up 100% (21,839 users) over the previous 134 days; user sessions are up 100% (32,712 sessions); pageviews are up 100% (146,883 page views); and total number of orders received from January 2022 to July 2022 is 270. “I believe we are on the correct path, and it’s all about staying the course, building revenue, keeping the debt capital out or to a minimum, and moving our valuation up now that our past restructure debt is behind us,” Rositano Jr. added. “We will be continuing to raise capital under the terms of our qualified Regulation A stock offering, as well as operationally continuing to test, re-organize offers and adapt the tech to allow for our scale, it’s happening, and our team has full confidence as we proceed with our next phases.” For more information, visit the company’s websites at www.Friendable.com or www.FanPassLive.com. NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

• Golden Matrix Group recorded revenue growth of +355% YoY in 1QFY22, the highest growth rate within the online gaming sector
• Golden Matrix attributed part of the increase to strong revenue contributions from UK-based RKingsCompetitions Ltd, which it purchased an 80% stake in as of November 2021
• RKings has emerged as one of the UK’s largest online competition companies, reporting revenues of over $32 million last year
• The acquisition of RKings bodes favourably for GMGI’s bid to further expand their B2C segment whilst geographically diversifying their revenue stream away from their traditional Asia-Pacific based B2B clientele

The online gaming market is on a roll. In the first quarter of FY2022, online gaming providers on averages saw their revenues rise by 24 percent year-over-year; however, that belied the true picture, with median growth rate for the sector rising by 6 percent relative to the first quarter of FY2021. Rather, the results were skewed by rapidly growing outliers, no more than that recorded by Golden Matrix Group (NASDAQ: GMGI), a developer and licensor of online gaming platforms, systems, and gaming content. Golden Matrix Group reported 1QFY22 revenue growth of 355 percent year-over year, over twice the rate of the next fastest growing company within the sector and outpacing the likes of betting industry stalwarts such as Penn Interactive Gaming, Flutter US, and DraftKings (https://ibn.fm/H9xVS). Golden Matrix Group saw its revenues rise to $8,482,743 million for the second quarter, with net income rising to $586,984 over the same interim, a significantly increase relative to the $127,986 recorded in the equivalent period a year ago (https://ibn.fm/SM2Qv). Golden Matrix Group attributed part of the significant increase in year-over-year revenues to the 28% increase in GMGI’s B2B segment’s top-line, in addition to strong revenue contributions from RKings. Golden Matrix Group acquired an 80 percent controlling stake in UK-based RKingsCompetitions Ltd in November 2021, with the company said to contribute approximately 60 percent of GMGI’s total revenues in the quarter. With active clients of more than 15,000 per month and having generated revenues of upwards of $32 million USD in their most recent fiscal year ending October 31, 2021, RKings has established a robust reputation as one of Ireland’s and the United Kingdom’s leading independent online competition companies. The firm operates a prize competition business offering customers in Ireland and the United Kingdom paid for entry, and free entry, routes to enter prize competitions to win a range of consumer products as prizes. In mid-May and following their recent stake acquisition, GMGI announced that they would be launching a robust upgraded Tournament Platform with added features and functionality for RKings’ players in Ireland and the United Kingdom; the upgraded platform is expected to increase both the monthly number of skill tournaments and participants, thus generating even stronger revenue and profit from RKings’ prize competition business. Moreover and as it is highly scalable, the platform can be introduced into other regulated markets with GMGI planning to go live with the platform in Mexico once its Mexican gaming permit has been approved. “This significant upgrade to the RKings platform will accelerate the growth of our B2C businesses, offering added functionality and features and also allowing us to expand into new geographic regions and strengthen our global footprint,” said Golden Matrix CEO Brian Goodman during a recent interview (https://ibn.fm/UlZnz). “We believe the GMGI/RKings product offerings will be received enthusiastically by players in all regulated markets where we are licensed. At a time when global economic growth is being challenged, we are fortunate to have a scalable business model that has already demonstrated consistent profitability.” Providing Golden Matrix with both, the means to diversify away from their traditional revenue base – historically comprised of licensing fees received from gaming operators located in the Asia Pacific region, as well as growing out its relatively nascent B2C business segment, the acquisition of RKings alongside the ongoing organic growth recorded within GMGI’s core business bode favourably for the company’s prospects going forward. For more information, visit the company’s website at www.GoldenMatrix.com. NOTE TO INVESTORS: The latest news and updates relating to GMGI are available in the company’s newsroom at https://ibn.fm/GMGI

With the right skills, suppliers, and foresight, the adoption of AI techniques is shown to accelerate drug pipeline development. To carry forward this important discussion, DGE is organizing the AI & Machine Learning for Drug Development Summit on August 25-26, 2022, as a virtual event. The event is hosted by Dynamic Global Events (“DGE”), a Life Science leader in organizing B2B events. The global event company caters to the dynamic informational and networking needs of the Pharmaceutical, Biotechnology, Healthcare, Medical Devices, and allied industries.  Pharmaceutical, biotech, and medical device professionals are invited to be a part of this event. Eminent industry heads and experts will explain how AI and ML can accelerate drug design, target identification, lead optimization, and early safety assessments. Attendees will also learn about the challenges to streamlining AI concepts into a market-leading reality, and the associated expertise required. As per a report from Accenture, by the year 2026 big data will, in conjunction with machine learning and artificial intelligence, generate over $150 billion annually for the life science sector. Primary Topics Of Discussion:

• Adopting proven AI and ML techniques to speed up timelines and allow for faster data gathering
• Integrating effective technologies into the design to accelerate action items
• Improving processes by using innovative ways to reduce workload and cost efficiencies
• Establishing effective vendor management procedures
• Dealing with the difficulties, and learningkey lessons, for post-COVID AI growth
• Discovering AI/ML Drug Development Methodologies in Oncology

The event commences with the chairperson’s opening remarks, followed by a discussion on processing healthcare data to a sustainable digital transformation using semantic knowledge. Other important topics include harnessing data for real-world evidence to increase end-to-end drug development and values. Experts will also offer insights into learning the underlying computational methodologies that are broadly applicable and which can easily extend to many other areas of digital medicine. They will also offer tips on how to speed up use of AI in your organizational Infrastructure. Attendees will learn how AI, machine learning, deep learning, and big data analytics, are evolving to be a critical aid to precision medicine. Finally, attend the summit to learn how to develop truly effective strategies for collaboration, recognizing partnership potential, and developing better drugs. To learn more please visit https://ibn.fm/eoeKA.

• The home energy market represents one of the most overlooked opportunities for sustainable energy investment to dramatically reduce carbon emissions
• GeoSolar Technologies has developed a patent pending whole-house system using geothermal, solar, and more to transition to energy independent homes
• The company is preparing a Regulation A+ offering to raise capital ahead

With record temperatures in England and heat advisory warnings for one-third of the U.S. recently, there is a lot of chatter about global warming and the need for a more aggressive approach towards reducing carbon emissions. Rising gasoline prices put the emphasis on electric vehicles, but there are other opportunities that can be equally impactful that are relatively unaddressed by the media, namely the home market. On that front, GeoSolar Technologies (“GST”) is the company to get to know for its sustainable home energy innovation. In fact, “There may not be a company in the climate technology industry that is doing more in the battle against rising global temperatures,” according to Marilyn Lopez, Partner and Co-Founder of TAG Collective. TAG is overseeing marketing efforts for GeoSolar Technologies related to the company’s upcoming Reg A+ offering to raise capital ahead of coming public. GeoSolar is taking a holistic approach to redefine how people heat, cool, cook, power, and purify homes with 100% sustainable energy sources. The Denver-based company’s patent pending SmartGreen(TM) home system harnesses energy from the Earth and sun to naturally power homes and EVs without fossil fuels. The whole-house system uses integrated floor loops and air ducts for heating, cooling, and hot water. Electricity is generated from a rooftop photovoltaic solar system. GeoSolar’s CERV(R) Air Filtration technology provides safe indoor air quality that prevents COVID-19 and other pollutants. The result of the system, branded GeoSolarPlus, is an efficient, energy independent, self-sustaining home that greatly reduces the homeowner’s carbon footprint. This is a massive emerging market. In 2018, energy expenditures averaged $3,891 per person. Extrapolating that out across about 327 million people in the U.S., about $1.3 trillion was spent on energy that year. According to the Environmental Protection Agency, electricity and heat production were responsible for 25% of 2010 global greenhouse gas emissions. The burning of coal, natural gas, and oil for electricity and heat is the largest single source of global greenhouse gas emissions. In 2021, there were an estimated 141.95 million home in America, each responsible for roughly 12,000-14,000 pounds of carbon annually. If all those homes transitioned to the SmartGreen(TM) system, pollution would be reduced by a whopping 1.9 trillion pounds each year. It’s possible, as GeoSolarPlus can be retrofitted to existing homes of built into new developments. Install only takes a few weeks. GeoSolar brings it all to the table to upgrade a home. The process is robust, starting with an initial analysis by an environmental inspector and design work, through the actual upgrades, such as decontamination and insulation, geothermal drilling, and installation, well drilling, purification system, and solar PV system installation. The package even includes all new LED lights, electric car charging station, digital thermostat, and application for controlling and monitoring air quality and energy usage. The SmartGreen(TM) home technology has been installed in multiple test homes in Colorado and achieved exceptional results with some of the most impressive energy efficiency ratings (“HERS”) in the industry. “With GST’s SmartGreen(TM) technology, we’re not just using the latest in solar and battery storage, we’re introducing a whole new and cleaner eco-luxurious lifestyle,” says Stone Douglass, Chairman and Chief Executive Officer of GeoSolar. For more information, visit the company’s website at www.GeoSolarPlus.com. NOTE TO INVESTORS: The latest news and updates relating to GeoSolar Technologies are available in the company’s newsroom at https://ibn.fm/GST

• LQwD has 17 active nodes worldwide on the Lightning Network
• Current nodes include Italy, Indonesia, Canada, France, Japan, England, Bahrain, South Africa, South Korea, Sweden, Singapore, Hong Kong, Brazil, Germany, India, Ireland, and the United States
• US-West holds the highest capacity at 5.970784520 BTC and a channel count of 115, followed by France, with a capacity of 2.62276941 BTC and 57 channels
• The cryptocurrency market size was valued at US $1.6 billion in 2021. It is expected to reach US $2.2 billion by 2026, growing at a CAGR of 7.1% over the forecast period

LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), a financial technology company focused on creating enterprise-grade infrastructure to drive bitcoin adoption, has announced the appointment of Aziz Pulatov as Chief Technology Officer, replacing Albert Szmigielski, who has resigned from the position but will remain as a strategic advisor to the company. Mr. Pulatov has extensive experience in the industry as a senior software architect and Bitcoin expert. He is a senior DevOps engineer and Amazon Web Services-certified SysOps Administrator. The company expressed gratitude to Mr. Szmigielski for his many contributions and looks forward to what he will bring in his new adversarial role for the company (https://ibn.fm/K6v9O). LQwD has launched 17 active nodes on the Bitcoin Lightning Network spanning multiple countries to facilitate faster transactions with lower fees. The first node (US-West) was launched in November 2021, around the same time the company launched its platform-as-a-service (“PaaS”) offering, lqwd.tech. LQwD’s PaaS solution allows users worldwide to send and receive Bitcoin on the Lightning Network instantly, securely, and inexpensively. The company expects the Lightning Network to be a force for global change and the monetary exchange of the future – and with this expectation, it has invested its own Bitcoin assets into the Lightning Network to facilitate node growth. LQwD’s worldwide nodes include Italy, Indonesia, Canada, France, Japan, England, Bahrain, South Africa, South Korea, Sweden, Singapore, Hong Kong, Brazil, Germany, India, Ireland, and the United States. The company has seen substantial growth in the capacity of its active nodes on the Lightning Network, with US-West holding the highest capacity thus far at 5.970784520 BTC and a channel count of 115. The next highest capacity node owned by the company is France, with a capacity of 2.62276941 BTC and 57 channels. The company’s node across the Lightning Network have now forwarded over 100 BTC, equivalent to just over US $3,000,000. The cryptocurrency market size was valued at US $1.6 billion in 2021. It is expected to reach US $2.2 billion by 2026, growing at a CAGR of 7.1% over the forecast period. This growth is attributed to the economic conditions and the rise in demand for cryptocurrency across various applications. The launch of various hardware and software companies has been a driving factor in the industry’s growth (https://ibn.fm/Y7qtF). LQwD is leveraging these factors to set sights on increasing the number of nodes available on the Lightning Network. The company plans to activate more nodes worldwide, increasing its presence as a trusted PaaS on the Network. For more information, visit the company’s website at www.LQwDFinTech.com. NOTE TO INVESTORS: The latest news and updates relating to LQWDF are available in the company’s newsroom at https://ibn.fm/LQWDF

• PBS News Hour estimates that, for college students, concussions cost between $446 million and $1.5 billion annually, while for high school students the cost ranges from $5.4 billion to $19.2 billion
• Odyssey, through its flagship product, PRV-002, hopes to offer the first FDA-approved drug treatment for concussions
• Once approved, Odyssey is confident that PRV-002 will bring relief to thousands of victims, reduce the cost of concussion treatment and allow victims to lead normal, healthy, and productive lives
• The company is currently scheduling a meeting with the FDA to present findings from the phase I trial, as it identifies phase II trial sites and creates the study design for other subsequent studies

According to the University of Michigan Health, every year in the United States, there are about 3.8 million concussions from sports-related injuries. The Center for Disease Control (“CDC”) further estimates that 5-10% of athletes will experience a concussion in any given sports season, with most of these injuries going undiagnosed or even unreported (https://ibn.fm/ofqNR). The economic impact of these conditions is significant, with PBS News Hour estimating it to be between $446 million and $1.5 billion a year for individuals in college. In contrast, for high school students, the cost ranges from $5.4 billion to $19.2 billion (https://ibn.fm/kvZio). While extensive research has been conducted on treating these concussions and related complications, most solutions have revolved around proper recovery management, primarily dependent on the type of concussion suffered or the symptoms experienced. For example, a concussion that leads to damage to the vestibular prompts vestibular rehabilitation. In addition, patients diagnosed with cognitive damage following a concussion are often prompted to take regular breaks, reduce workload, stick to a strict diet and stay hydrated, among others (https://ibn.fm/Id9vc). Odyssey Health (OTC: ODYY) is pushing the envelope with concussion research and treatment. As a medical technology company focused on developing lifesaving medical products that offer technological and clinical advantages over current standards of care, Odyssey has remained committed to delivering superior products with enhanced clinical utility and market potential. This has seen the introduction of two key pharmaceutical products- PRV-002 and PRV-001. PRV-002 is Odyssey’s flagship product, a novel compound for concussion treatment. Pre-clinical studies on this compound have shown to significantly improve both neuroscore and memory score following injury in rats subjected to concussion models. The product is currently being evaluated in a phase I clinical trial, following the successful completion of all three cohorts of its Phase I Single Ascending Dosing (“SAD”) clinical trial. While speaking on the RedChip Money Report, Odyssey’s spokesperson, Bret Favre, highlighted the significance of the company’s research and the value it holds, not just to current football players in the United States but also to all future athletes. As a former American football quarterback with 321 consecutive starts over 18 years, and a seat at the Pro Football Hall of Fame, Mr. Favre has had his fair share of concussions. He notes the price he has paid for playing the game and suffering all those concussions, including memory loss issues. “I just go day-to-day, year-to-year hoping that the repercussions from the concussions are not as serious as they’ve proven to be,” he noted. “I’m passionate about seeing something change so many lives in the game I love. I would love to know that there is a solution for concussions other than ‘we [are] going to change the rules,’ ‘we [are] going to get better helmets….’ It’s something I’m very passionate about and want to see through to the end,” he added (https://ibn.fm/kjRYJ). Odyssey is confident that PRV-002 will receive the American Food and Drug Administration (“FDA”) approval once all the necessary procedures are undertaken. The company is currently scheduling a meeting with the FDA to present the findings from the phase I trial, even as it identifies phase II trial sites and creates the study design for this and other subsequent studies. Once sanctioned, PRV-002 will become the first FDA-approved drug treatment, bringing relief to thousands of victims in the United States and the world over. Odyssey is optimistic that the cost incurred by victims will be significantly reduced with its drug approval, allowing victims to lead normal, healthy, and productive lives. For more information, visit the company’s website at www.OdysseyHealthInc.com. NOTE TO INVESTORS: The latest news and updates relating to ODYY are available in the company’s newsroom at https://ibn.fm/ODYY

• CubCrafters owns 15 undeveloped acres at McAllister Field for potential expansion of operations
• The company recently opened a new 11,000-square-foot Customer Completion Center
• Cost and timeline of FAA Certification represents a significant barrier to entry
• The company introduced its CC19-180 XCub aircraft in June 2016, completing the six-year project without using any outside investment
• The company recently released new variants of the XCub offering floats and more engine horsepower
• New nosewheel configurations open up the company’s product line to 85% of all pilots
• Only 10-12% of CubCrafter’s sales are international, though it represents 50% of the market demand – an untapped opportunity for growth
• Financing will dramatically reduce order backlog resulting in a strong revenue rise and accelerating future growth
• The Builder Assist program, unique to CubCrafters, is a large and growing sales segment
• The company’s legacy of innovation distinguishes it from its peer group
• The global ultralight and light aircraft market was valued at $7.63 billion in 2021 and is expected to grow at a CAGR of 4.5% from 2022 to 2027 to reach a forecast value of $9.93 billion

Cub Crafters (typically styled CubCrafters) is an OEM aircraft manufacturer based at McAllister Field Airport in Yakima, Washington. The company was founded in 1980 to build parts and supplementary type certificate (“STC”) improvement modifications, which were used to establish it as the preeminent center for rebuilding the classic Piper PA-18 Super Cub light aircraft. CubCrafters went on to advance the market with its own, newly manufactured aircraft models and holds an approved Federal Aviation Administration (“FAA”) Production Certificate. Yakima-based operations include an engineering design-test-certification center, aircraft parts and assembly production facilities, and an MRO maintenance service and overhaul facility. The first newly manufactured aircraft by the company, the CC18-180 Top Cub, was Federal Aviation Administration (“FAA”) type certified in December 2004. The Top Cub was also granted type certificates (“TC”) by Transport Canada in July 2008, followed by Australian certification in August of that same year. With the FAA’s release of the new Light Sport Aircraft (“LSA”) class, CubCrafters created a brand-new model in 2008, the CC11-100 Sport Cub, similarly based on the original Piper J-3 Cub’s appearance, which it validated to ASTM international standards as an LSA. This model advanced to become known as the Carbon Cub, the bestselling LSA of all time in the U.S. CubCrafters focuses on four main product lines, including the Carbon Cub SS, Carbon Cub FX, XCub, and the Top Cub under license. Some models are built to be lightweight and powerful for quicker flights, while others are built for longer missions in unforgiving backcountry environments. CubCrafters has a service and overhaul facility for PA-18 Super Cubs and other Cub derivative designs at its Yakima headquarters. The company sells aircraft kits as well as finished aircraft. Aircraft The Carbon Cub is available in three variants: Carbon Cub SS (production Light Sport Aircraft), Carbon Cub FX (an innovative Builder Assist E/A-B aircraft) and Carbon Cub EX (E/A-B aircraft kit). Carbon Cub has been designed for off-airport operation with a powerful engine, strong lightweight airframe and nimble low-speed manners. The Carbon Cub has taken the fundamentally superior design of the Piper Super Cub and reinvented it using 21st century materials and computer-aided design. Superior engineering results include the Carbon Cub having 50% fewer parts and weighing more than 300 pounds less than a similarly equipped Super Cub. Now in its third generation of innovation advancements, there are over 1,000 Carbon Cubs flying. The CubCrafters CC19-180 XCub, FAA Certified and introduced in June 2016, is supplied complete and ready-to-fly. The XCub is a further scaled development of the CubCrafters Carbon Cub, which the company continues to supply, but with higher performance and incorporating more structural carbon fiber. The XCub was developed over a six-year period and not publicly announced until FAA TC had been completed and issued. The process was completed organically using company resources and did not involve any venture capital, loans nor any advanced customer deposits. XCub is built on a wholly original fuselage design. The CNC-milled 4130 chromoly steel frame meets the latest FAA Part 23 certification standards for 2,300-pound gross weight aircraft. XCub’s useful load is as high as 1,084 pounds. Current Part 23 certification requirements ensure this is the strongest Cub ever produced. It can fly farther, providing greater comfort. It is an airplane that has taken the best from the past and, using the very latest in design, material and manufacturing technology, has established a new standard. The XCub was approved by the FAA for seaplane operations in December 2017. That same month, EASA approved the XCub design and issued a new type certificate. Four international type certificates have been gained: EASA Dec-2017, Canada Feb-2018, Japan April-2018, and Australia Aug-2018. CubCrafters increased the horsepower of the XCub line in 2019, offering two new models: the CC19-215 FAA Certified version and the CCX-2300 Builder Assist, both powered by the new CC393i 215 HP engine built by Lycoming. In December 2021, CubCrafters gained FAA Certification of a new nose wheel version of the XCub, branded the NXCub. Market Overview According to a 2022 analysis by research firm Expert Market Research (“EMR”), the global ultralight and light aircraft market was valued at $7.63 billion in 2021. The EMR report says the market is expected to grow at a CAGR of 4.5% in the forecast period of 2022-2027 to reach a value of $9.93 billion. Ultralight and light aircraft are small aircraft with on-board pilot (and perhaps passengers) designed for use in recreation, sports, pilot training, aerial surveys, mapping, research and agriculture, humanitarian backcountry access, and special military missions, as well as business and personal travel. CubCrafters currently enjoys a dominant market share of the rugged adventure airplane market. Management Team Patrick Horgan is President and CEO at CubCrafters. Before he assumed that role, he was the company’s Vice President/Director of Engineering & Product Development for three years, when he led the FAA Part 23 type certificate approval and production certificate approval of CubCrafters’ newest flagship, the XCub. Mr. Horgan also directed the breakthrough certification that authorized the use of experimental avionics in FAA-certified production aircraft, a first in aviation history. He brings over 30 years’ aircraft development and manufacturing experience in general aviation, commercial, and military industries. Prior to service at the company, he was the General Manager at WACO Classic Aircraft Corporation in Battle Creek, Michigan, and was the commercial aircraft manager of the Boeing 777 wheel and brake program for Goodrich Aerospace in Troy, Ohio. He was also a designer on the F/A-18 Super Hornet at McDonnell Douglas (now Boeing) in St. Louis, Missouri. Mr. Horgan holds degrees in aeronautical and astronautical engineering from the University of Illinois, and a certificate in Disruptive Strategy from Harvard Business School. He serves as a member of the Board of Directors of the General Aviation Manufacturers Association and on ASTM aircraft standards committees. Brad Damm is Vice President at CubCrafters. He has overseen CubCrafters’ sales, marketing, and brand management operations since 2018. Since first joining CubCrafters in 2013, Mr. Damm has served as Factory Direct Sales Manager, the Director of Sales Support, the Global Director of Sales, and the Vice President of Sales and Marketing. During his tenure, the company has seen new sales records year after year across all of CubCrafters new aircraft and kit product lines, and the CubCrafters brand has risen to new levels of awareness and respect with aviation consumers worldwide. Prior to joining the company, he served for over 10 years as the Business Development Manager for one of the largest commercial concrete contractors in the Pacific Northwest, driving the sales and revenue growth that allowed the company to expand from a few dozen to hundreds of employees. Rick Johnson is the Director of Finance at CubCrafters and has been with the company since 2017. He has 27 years of previous experience as controller and CFO for fruit packing and timber operations in the Pacific Northwest. He holds a Bachelor of Science in Business Administration from Central Washington University. Christopher Matus is Production Manager at CubCrafters and joined the company in 2011. Before taking that post, he held positions as Fabrication Plant Manager, Machine Shop Manager and CNC Machinist for the company. He has also served as a Combat Engineer in the Washington Army National Guard, deploying to Afghanistan and to natural disasters including the 2014 Oso Mudslide. Justin Jansky is the Administrative Manager at CubCrafters. He joined the company in 2015 and has a demonstrated history of successful collaboration on major FAA type certification projects in the general aviation industry, specifically under 14 CFR Parts 21 and 23. He is responsible for process management, document control, facilitating FAA certification processes, coordination with FAA delegates and documenting compliance testing. He holds a bachelor’s degree in technology and applied design. For more information, visit the company’s website at www.CubCrafters.com. NOTE TO INVESTORS: The latest news and updates relating to Cub Crafters Inc. are available in the company’s newsroom at https://ibn.fm/CUB

• Lexaria, a global innovator in drug delivery technology, has developed the patented DehydraTECH(TM) technology which has been the subject of several issued patents
• Recently, Lexaria reported it had been notified of the allowance of its 26th worldwide patent with a new patent to be granted in Japan
• The patent is the fourth to be granted in Japan and the first patent issued from Lexaria’s seventh patent family
• Lexaria also submitted a briefing book to the FDA to facilitate its upcoming pre-Investigational New Drug (“IND”) meeting with the agency

“We are extremely pleased to have received our first patent protecting our proprietary technology… I expect our intellectual property portfolio to continue to expand,” said Lexaria Bioscience (NASDAQ: LEXX) CEO Chris Bunka in an October 2016 press release announcing that the company had been issued U.S. Patent No. 9,474,725, Cannabinoid Infused Food and Beverage Compositions and Methods of Use Thereof, by the U.S. Patent and Trademark Office (“USPTO”) (https://ibn.fm/iW3Ai). Since receiving this patent, its first ever, which pertains to LEXX’s method of enhancing bioavailability and taste of specific cannabinoid lipophilic active agents in food products, the company has amassed an impressive portfolio worldwide that includes patents granted in India, Australia, Japan, the U.S., Mexico, and Europe, and is, in fact, still growing as its patent applications advance to granted patents. Lexaria is pursuing patent protection in over 40 countries and currently has roughly 50 pending patent applications globally (https://ibn.fm/R3jaO). In a development that now pushes the number of granted patents worldwide to 26, Lexaria recently reported it had been notified of the allowance of a new patent to be granted in Japan, the fourth to be granted in that country. Entitled Lipophilic Active Agent Infused Compositions with Reduced Food Effect, this is the first patent issued from Lexaria’s seventh patent family and refers to tetrahydrocannabinol (“THC”) (https://ibn.fm/Hr8E2). The new patent acknowledges DehydraTECH(TM)’s ability to deliver active pharmaceutical ingredients (“APIs”) more efficiently, in a process known as absorption, regardless of the presence of food in the gastrointestinal system. Ordinarily, food impacts drug absorption by physically interacting with drugs, altering the pH, stimulating bile flow, slowing gastric emptying time, or increasing splanchnic blood flow (https://ibn.fm/Udtkw). But DehydraTECH, Lexaria’s patented drug delivery technology, delivers drugs more consistently into the bloodstream regardless of this food effect. The drug delivery technology achieves this through its use of fatty acid oil. Lexaria’s technology joins the API’s molecules in what is believed to be a “barbell-shaped” structure that allows the body to detect both molecules while enhancing taste and absorption. The body’s detection and natural processing of the long chain fatty acid is part of Lexaria’s clever patented process that also enhances the API absorption. Bioavailability refers to both absorption levels and the time required to absorb. “In order to feel something quickly, you need to avoid something that’s known as fast-pass liver metabolism. When you eat food, it goes into your stomach, then it goes into your intestine, and then most of the nutrients go into your liver for filtration before they get into the bloodstream. That takes about an hour and a half, on average. But [using] our technology, we are able to divert the molecules away from the liver, and that allows you to get feelings or experiences in as little as 15 to 20 minutes,” Chris Bunka continued. Meanwhile, Lexaria also reported it had submitted its briefing book to the U.S. Food and Drug Administration (“FDA”). This documentation will facilitate a pre-Investigational New Drug (“IND”) meeting that LEXX had requested in an early June letter to the FDA. The FDA provided a target date of July 30, 2022, for a meeting or comments. For more information, visit the company’s website at www.LexariaBioscience.com. NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

• Silo Pharma produced initial batch of SPU-21 liposomes for rheumatoid arthritis study conducted by CRO Frontage Laboratories
• Recent company research revealed SPU-21 liposomes can target inflamed epithelium, suggesting use for targeted drug delivery
• SPU-21 can be used for development of fusion imaging molecules and/or nanoparticles to study arthritic pathogenesis
• Company recently announced positive results in subcutaneous delivery of novel liposomes vs. intravenous injection

Silo Pharma (OTCQB: SILO), a developmental stage biopharmaceutical company that focuses on fusing traditional therapeutics with psychedelic research, recently announced it had produced an initial batch of SPU-21 liposomes for a rheumatoid arthritis study conducted by Frontage Laboratories, a contract research organization (“CRO”) (https://ibn.fm/BizI3). Recent research by the company revealed that SPU-21 liposomes have the ability to target inflamed epithelium, suggesting they can be used to target drug delivery. Further, SPU-21 can potentially be used to develop fusion imaging molecules and/or nanoparticles to study arthritic pathogenesis. According to the research, this approach may enhance therapeutic effects and decrease potential toxicity despite systemic administration of the drug. “The production and delivery of liposomes for our upcoming study with Frontage advances SPU-21 and allows us to further study anti-arthritic activity in animals,” said Eric Weisblum, CEO of Silo Pharma. “We look forward to sharing the results of the study upon completion and data collection.” In addition, Silo recently announced positive results in subcutaneous delivery of its novel liposomes to treat arthritic patients (https://ibn.fm/XeEiQ). This contrasts with previous animal research testing ART-1-Cy7 liposomes using intravenous injection, suggesting that subcutaneous administration possibly trends higher than intravenous injection with fewer toxic effects. “The successful results of our study show that the subcutaneous route of liposomal administration is well-suited for use in targeted drug delivery of anti-arthritic agents,” said Weisblum. “We suggest that this drug delivery approach would not only enhance efficacy but also reduce systemic toxicity.” ​Silo partners with leading universities to further treatment research for various mental and physical indications. The company recently extended its exclusive option agreement with the University of Maryland, Baltimore, to explore joint-homing peptides to treat arthritis in addition to Multiple Sclerosis (“MS”). In addition, the company signed an agreement with Columbia University that granted an option to license developmental assets that include an Alzheimer’s disease formulation as well as a prophylactic treatment for post-traumatic stress disorder (“PTSD”). Silo is dedicated to leveraging innovative solutions to help people suffering from indications such as rheumatoid arthritis, fibromyalgia, post-traumatic stress disorder (“PTSD”), Parkinson’s disease, Alzheimer’s disease, and other rare neurological disorders. The company identifies and partners with leading medical universities, providing financial resources that catalyze the progress of cutting-edge research through the clinical stage and into commercialization. For more information, visit the company’s website at www.SiloPharma.com. NOTE TO INVESTORS: The latest news and updates relating to SILO are available in the company’s newsroom at https://ibn.fm/SILO

• Nearly a decade has passed since approximately 200 government entities met in Paris, ratifying a binding agreement to work toward reducing pollution and its negative impacts on global climate
• Louisiana-based Correlate Infrastructure Partners is helping to educate corporate clients on both the affordability and potential profit offered by ESG solutions that reduce their greenhouse gas impact
• CIPI’s Correlate, Inc. and Loyal Enterprises LLC (dba Solar Site Design) subsidiaries provide related help on acquisitions and project development, as well as resource financing
• A recent report by consulting firm McKinsey & Company forecasts growing adoption of renewable energy solutions by the public, but at a pace that will, at the current rate, fall short of the established Paris goals

Purpose-built energy use optimization company Correlate Infrastructure Partners (OTCQB: CIPI) works with business clients to improve their facilities’ consumption of utilities and production of greenhouse gases. Environmental, social and governance (“ESG”) initiatives have become increasingly important amid concerns about climate change and its expected negative effects on society. In April, Renewables e-magazine noted that green energy solutions are increasingly forming the basis for utilities related decisions, and that global management consulting firm McKinsey & Company’s latest report on the energy sector predicts that by the end of the decade approximately 50 percent of power resources will be based upon renewables, and that this percentage will rise to 85 percent by 2050. The costs of implementing solar or onshore wind power have previously made such solutions inaccessible to some companies and utilities. However, as their expense has fallen, they have become more attractive. “Rapid technological developments and supply chain optimization have collectively halved the cost of solar, while wind costs have also fallen by almost one-third,” McKinsey senior partner Christer Tryggestad stated in conjunction with the report (https://ibn.fm/JQ5lw). “However, even if all countries with net zero commitments deliver on their aspirations, global warming is still expected to reach 1.7°C. To keep the 1.5°C [Paris Agreement] pathway in sight, even more ambitious acceleration is needed.” The 2015 Paris Accords have had nearly a decade to work on the public consciousness of concerns about changing weather patterns which scientists verify are prompted by manmade pollutants. Political factions, resistant to changes and decisions that might include higher costs in order to reduce pollution, have slowed the pace of new policy adoption, but activists continue to see optimism in the trends toward large-scale acceptance. Still, the McKinsey report’s statement that the countries involved in the agreement are only on pace to achieve a 1.7 degree increase over pre-industrial levels by mid-century indicates that the global climate is still going to experience upheaval if a larger response doesn’t occur. Correlate Infrastructure Partners provides education to companies and organizations on both the affordability and potential profit of their environmentally friendly solutions. Through CIPI’s advisory assistance on acquisitions and project development, paired with development and financing resources, the company is helping to turn ESG strategies into a financially viable reality. Clients simply need to provide CIPI with 12 months of utility bills and opt-in to CIPI’s advisement. Determined solutions may involve improvements to HVAC, mechanical, electrical and plumbing processes, the addition of solar upgrades, water optimization and antimicrobial airflow, the strategic procurement of energy sources, vehicle electrification, and master controls that provide intelligent oversight of any retrofits. The reporting process provides a thorough and transparent analysis of what is achieved through these solutions, and how they can represent not only affordability but potential profit for the companies and organizations being served. For more information, visit the company’s website at www.CorrelateInfra.com, including the following:

• Breaking Down Barriers To Your ESG Goals While Generating Additional Net Operating Income: www.CorrelateInfra.com/our-process
• Platform Generates New Rent And Operating Income, Allowing You To Meet Your ESG Goals: www.CorrelateInfra.com/program

NOTE TO INVESTORS: The latest news and updates relating to CIPI are available in the company’s newsroom at https://ibn.fm/CIPI